California Voters Demand Action on Healthcare Costs as Patients Buckle Under Financial Strain

When Ashley Porter first noticed her speech becoming slurred on an autumn afternoon four years ago, her initial instinct—echoed by the emergency medical professionals who first evaluated her—was that she had suffered a stroke. What followed was a grueling diagnostic odyssey: a spinal tap, a magnetic resonance imaging scan, dozens of blood draws, a second MRI, and an overnight stay in a hospital monitoring ward. Finally, specialists provided a definitive answer: Porter had multiple sclerosis, a chronic, unpredictable disease of the central nervous system.

For Porter, the initial shock of her diagnosis quickly curdled into profound outrage when she received a hospital billing statement totaling approximately $180,000. Even though her health insurance policy covered the lion’s share of the charges, the remaining out-of-pocket costs were staggering. Today, Porter and her husband maintain coverage through two separate employer-sponsored health plans, yet they have been forced to allocate at least $75,000 annually—roughly a quarter of their combined gross household income—toward medical expenses since the date of her diagnosis.

"It is terrifying," said Porter, who works in transportation sales in the San Francisco Bay Area. "I can’t imagine having this disease and not making the kind of income that we make."

Porter’s harrowing experience is far from unique. Across the United States, healthcare insurance premiums and hospital service prices continue to outpace overall economic inflation. More than 40% of American adults nationally now struggle to afford basic medical care, fueling widespread public demand for legislative and regulatory intervention. In California—the nation’s largest healthcare market—the crisis has reached a boiling point, dominating voter concerns ahead of the upcoming gubernatorial election while testing the policy proposals of the candidates vying for the state’s highest office.

The Rising Financial Toll on California Families

The financial strain facing California households is well-documented by recent economic and public health surveys. The average annual premium for a family living in California with employer-sponsored health insurance coverage has surged to nearly $28,400. This represents an alarming 24% increase since 2022, vastly outpacing the growth rate of typical worker wages during the same period.

Amid these skyrocketing expenses, gubernatorial candidates have rolled out policy platforms that critics argue remain frustratingly short on specific funding mechanisms and implementation strategies. This lack of concrete detail leaves voters searching for viable solutions to what has consistently polled as a top priority.

"People are hungry for pretty aggressive action on healthcare spending," said Kristof Stremikis, director of market analysis and insight at the California Health Care Foundation, a nonprofit philanthropic organization specializing in healthcare research and education. "Regardless of who our new governor is and who our new state policymakers are in the next year, they have a mandate."

According to a recent health policy survey conducted by the California Health Care Foundation and NORC at the University of Chicago, nearly two-thirds of Californians worry constantly about receiving an unexpected medical bill—a financial anxiety that surpasses traditional worries over the soaring costs of rent or food. Furthermore, 6 in 10 respondents reported that they or an immediate family member had intentionally skipped or delayed necessary medical care because they simply could not afford it.

Gubernatorial Candidates Trade Proposals as Healthcare Takes Center Stage

The political debate over how to solve California’s healthcare affordability crisis features two distinct approaches from the leading candidates in the race to succeed term-limited leadership.

Democrat Xavier Becerra, the former U.S. health secretary and former California attorney general who commands a substantial polling lead in the gubernatorial race, has anchored his campaign platform on aggressive market oversight and legal enforcement. Becerra has vowed to leverage state authority to negotiate lower prescription drug prices and aggressively target anticompetitive practices within the medical industry—a strategy mirroring his high-profile tenure as attorney general, which included a landmark antitrust settlement with hospital giant Sutter Health.

At the national level, Becerra has also advocated for congressional action to restore an estimated $900 billion in federal Medicaid funding cuts and to reinstate enhanced Affordable Care Act (ACA) tax credits. These tax credits were allowed to expire by federal lawmakers, triggering immediate premium spikes for millions of Americans nationwide. However, critics note that these federal policy interventions fall outside the direct purview and executive authority of a state governor.

On the other side of the aisle, former television host and political commentator Steve Hilton, Becerra’s Republican opponent, has proposed a different framework. Hilton’s platform emphasizes building upon existing state transparency laws and cracking down on pharmaceutical middlemen, known as pharmacy benefit managers, to drive down consumer costs. Additionally, Hilton has floated a proposal to partially replace Medi-Cal—California’s sprawling state Medicaid program—with personal healthcare accounts funded up to $10,000 per year. Political analysts note that this concept faces steep hurdles and is unlikely to gain legislative traction in a statehouse firmly controlled by Democratic majorities.

Despite the central role healthcare costs play in the election, both major-party candidates have declined multiple interview requests from journalists to discuss the intricate details of their proposed health policies.

A Chronology of Escalating Health Expenditures and Industry Consolidation

To understand how California arrived at this financial precipice, health economists point to decades of structural changes in the American medical marketplace. From 1970 to 2025, total U.S. healthcare expenditures ballooned from $75 billion to a projected $5.7 trillion, surging nearly 40% between 2020 and 2025 alone. Projections from the federal Centers for Medicare & Medicaid Services indicate that by the year 2032, total health spending will consume more than one-fifth of the entire U.S. gross domestic product.

A significant driver of this macro-level inflation is the relentless growth of payments directed to hospitals, specialty physicians, and outpatient clinics, compounded by persistently high prescription drug costs. Over the past three decades, a wave of corporate consolidation has swept through the healthcare sector. Mergers and acquisitions involving independent physician practices, regional hospital groups, and massive insurance conglomerates have systematically stifled market competition, giving dominant health systems unchecked pricing power.

A pivotal moment in this ongoing battle occurred in 2018, when then-Attorney General Xavier Becerra filed a landmark antitrust lawsuit against Sutter Health. The state accused the Sacramento-based, not-for-profit health system of leveraging its immense market dominance to inflate hospital prices across Northern California, where medical procedures frequently cost up to 30% more than in comparable regions of the state.

Under the terms of the subsequent settlement, Sutter Health admitted no wrongdoing but agreed to pay an unprecedented $575 million fine. The system also consented to halt specific controversial business tactics, including the enforcement of "all-or-nothing" contractual clauses that compelled commercial insurers to include the system’s entire network of clinics and hospitals in their coverage networks, regardless of cost or consumer preference.

"It was the biggest victory in antitrust and hospitals ever," recalled Richard Scheffler, director of the Nicholas C. Petris Center on Health Care Markets and Consumer Welfare at the University of California-Berkeley, whose foundational economic research directly informed Becerra’s legal action.

For Californians Drowning in Healthcare Costs, Governor’s Race Offers Few Answers

"But things change," Scheffler cautioned. While the historic settlement likely deterred similar predatory practices among competing hospital chains across the state, any temporary relief has since been overshadowed by a new, accelerated wave of healthcare industry consolidation.

The Human Cost: Medical Debt and Out-of-Control Bills

For everyday workers, the macroeconomic ripple effects of soaring healthcare costs are deeply personal. Economists emphasize that escalating health spending directly diverts capital that employers might otherwise allocate toward wage increases, bonuses, or new hires, thereby depressing overall wage growth.

For workers already struggling to make ends meet, this dynamic creates a punishing double whammy, sharply increasing the risk of accumulating debilitating medical debt. Recent data shows that 40% of all California adults currently carry some form of medical debt.

Kia Frazier-Hill and her husband never imagined they would fall victim to this cycle. When her husband suffered a medical emergency that required a sudden hospitalization at an out-of-network facility, Frazier-Hill anticipated a sizable bill, but the sheer scale of the itemized charges produced immediate sticker shock.

The hospital billing statement included charges of $17,507 for a single night in the intensive care unit; $427.89 for a standard respiratory panel testing for the flu, COVID-19, and respiratory syncytial virus (RSV); and $2.60 for a single tablet of generic, regular-strength Tylenol. Although their bronze-tier insurance plan purchased through Covered California—the state’s ACA marketplace—covered nearly $60,000 of the total expenses, a remaining balance of $7,500 went unpaid and was swiftly handed over to collections agencies.

"We’re drowning," Frazier-Hill said, expressing exasperation over the pricing structure. "It just doesn’t make any sense what they’re charging."

Independent health policy research consistently demonstrates that hospital prices are disproportionately higher in uncompetitive, monopolized regional markets. In an effort to corral these runaway expenses, California established the Office of Health Care Affordability. This state regulatory body has mandated that most major health systems, hospitals, insurers, and large provider groups cap their annual spending growth at 3.5%.

However, hospital executives and physician advocacy groups have strongly resisted the cap, arguing that the target is unrealistically restrictive and will ultimately degrade patient care rather than spur administrative efficiency. Notably, many of these same hospital and physician groups have contributed financially to political campaigns, including Becerra’s gubernatorial bid.

"Hospitals have a mission to take care of people, save lives, and that costs money," said Amber Ott, senior vice president of financial policy for the California Hospital Association, which has actively challenged the affordability board’s spending caps in state court. "It’s hard to look at just one piece of the ecosystem and say that’s where the problem is."

Despite pushback from providers, health data confirms that hospitals remain the single largest driver of overall health spending. According to state figures, at least 40% of total commercial health insurance spending in California during 2024 was funneled directly to hospitals.

Policy Options and the Path Forward

As public insurance programs absorb the shock of rising healthcare expenditures and state budget reserves face mounting pressure, state governments nationwide are increasingly stepping into the leadership void to mandate affordability measures. Yet, health policy experts note that California still lags behind several other states in implementing aggressive regulatory controls.

"There’s a lot more they could do to rein in underlying drivers of healthcare costs," said Sabrina Corlette, co-director of the Center on Health Insurance Reforms at Georgetown University.

For example, multiple states have enacted outright bans on "facility fees"—controversial charges that permit hospitals to bill patients at inflated outpatient rates for services rendered at clinics they own, even when those clinics operate independently from main hospital campuses. Corlette notes that facility fees artificially inflate patient costs while simultaneously incentivizing hospital networks to aggressively acquire independent physician practices.

Other states have pursued direct price regulation. Oregon successfully capped the payments its public employee health plans make to hospital networks, resulting in a nearly 10% reduction in patient out-of-pocket spending for outpatient procedures. Meanwhile, Rhode Island limits overall hospital cost growth through rigorous annual rate reviews of state-regulated health insurance plans. California has adopted neither mechanism.

California healthcare advocates and academic researchers suggest there are numerous straightforward policy adjustments available to lawmakers that could deliver immediate financial relief to consumers. Streamlining and automating notoriously inefficient prior authorization procedures, or establishing strict statutory timelines for insurer responses to authorization requests—as New Jersey and Vermont have successfully done—could eliminate unnecessary administrative friction and delays in care.

Additional policy proposals include broadening state-level bans on anticompetitive contracting practices, following the legislative models established in Connecticut and Texas. Lawmakers could also choose to expand successful local initiatives, such as Los Angeles County’s municipal program dedicated to purchasing and forgiving outstanding medical debt for local residents.

Nevertheless, healthcare economists warn that even modest legislative reforms face an uphill battle inside the state capitol in Sacramento, where the healthcare and pharmaceutical industries deploy lobbying budgets totaling tens of millions of dollars annually to influence lawmakers and regulatory agencies.

"It’s a big, complicated system, and the money is so gigantic," said Glenn Melnick, a healthcare economist at the University of Southern California. "At some point, the legislature has to hold the line and say, ‘Look, it is the golden goose, but we’re going to have to feed it a little bit less.’"